GBT

Global Blood Therapeutics, Inc.

Delisted

GBT was delisted on the 4th of October, 2022.

116 hedge funds and large institutions have $1.16B invested in Global Blood Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 41 increasing their positions, 25 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
116
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$19M
Puts
$13.4M
Net Calls
Net Calls Change

Top Buyers

1 +$94.5M
2 +$53.6M
3 +$40M
4
Citadel Advisors
Citadel Advisors
Florida
+$29.7M
5
PA
Perceptive Advisors
New York
+$26.9M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$212M
2
$142M
3
$96.5M
4
$93.5M
5
$85.5M
6
$53.6M
7
$40M
8
$34.4M
9
$30.9M
10
$30M
11
$29.7M
12
$24.8M
13
$19.9M
14
$15.1M
15
$12.7M
16
$12.3M
17
$11.8M
18
$11.1M
19
$9.67M
20
$9.44M
21
$9.02M
22
$8.26M
23
$7.54M
24
$7.37M
25
$6.45M